NASDAQ$LFST

LifeStance Health Group Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Reports awaiting report

LifeStance hasn't published Q1 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q4 2025

    Revenue
    $382M
    EPS
    $0.03
  • Year-ago · Q1 2025

    Q1 2025

    Revenue
    $333M
    EPS
    $0.00
  • FY2026 consensus

    Analyst consensus

    Revenue
    $1.59B
    EPS
    -$0.04

Revenue & EPS history

LifeStance · Revenue · Quarterly

$382M

Q4 2025+17.4%vs Q4 2024
Beat estimate in 7 of 14 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

-4.5%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.3%

Avg return

30 days after

42%

8 / 19 earnings

Positive

+24.6%

Q4 2023

Best reaction

-49.7%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+20.2%+7.7%
Q4 2025+4.3%+0.0%-11.5%
Q3 2025-3.6%+29.1%+30.1%
Q1 2025-16.0%-10.7%-10.8%
Q4 2024+3.1%+6.8%-10.8%
Q3 2024+3.2%+3.8%+2.9%
Q2 2024+1.6%+6.0%+26.1%
Q1 2024-1.7%+5.9%-19.1%
Q4 2023+24.6%+21.8%-3.4%
Q3 2023-9.4%-8.9%+7.9%
Q2 2023-5.0%-7.4%-17.1%
Q1 2023-1.4%+1.1%+1.7%
Q4 2022+22.2%+23.8%+65.6%
Q3 2022-30.4%-15.9%-23.0%
Q2 2022+6.2%+10.8%+29.3%
Q1 2022-13.9%+0.4%+10.1%
Q4 2021-12.7%-5.9%+4.2%
Q3 2021-27.3%-22.8%-29.1%
Q2 2021-49.7%-40.6%-30.2%
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro